FDA Inspection
Mount Sinai Medical Center-IRBMount Sinai Medical Center-IRB – FDA Inspection, Feb 11, 2014
Record Details
This FDA Inspection record concerns Mount Sinai Medical Center-IRB, with an inspection on February 11, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 11, 2014
- Product Type
- Drugs
View Company Profile
ID · f9eb0d2a-e0c8-44ad-9908-32cfdfb3b1fa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 866028
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 56.110(c)Method to keep members advised
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mount Sinai Medical Center-IRB
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2025 | Not classified | Florida District Office | |
| May 15, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 20, 2009 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Mount Sinai Medical Center-IRB
- FDA Inspection 1292472 - 2025-11-18
- FDA Inspection 1091475 - 2019-05-15
- FDA Inspection 621502 - 2009-10-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.